Medical test maker Ventana Medical Systems Inc. said on Aug. 17 a federal jury found it liable for $10.8 million in damages for infringing two of CytoLogix Corp.’s patents in a 2003 case.

Jurors of a U.S. District Court in the Eastern District of Massachusetts also found that Ventana is not liable for CytoLogix’s antitrust claims.